BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36847433)

  • 1. The risk of radiation-induced neurocognitive impairment and the impact of sparing the hippocampus during pediatric proton cranial irradiation.
    Gram D; Brodin NP; Björk-Eriksson T; Nysom K; Munck Af Rosenschöld P
    Acta Oncol; 2023 Feb; 62(2):134-140. PubMed ID: 36847433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of failure in pediatric medulloblastoma and implications for hippocampal sparing.
    Baliga S; Adams JA; Bajaj BVM; Van Benthuysen L; Daartz J; Gallotto SL; Lewy JR; DeNunzio N; Weyman EA; Lawell MP; Palmer JD; Yeap BY; Ebb DH; Huang MS; Perry AF; MacDonald SM; Jones RM; Tarbell NJ; Yock TI
    Cancer; 2023 Mar; 129(5):764-770. PubMed ID: 36504293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric Comparison of Helical Tomotherapy and Intensity-Modulated Proton Therapy in Hippocampus- and Scalp-Sparing Whole Brain Radiotherapy.
    Takaoka T; Tomita N; Mizuno T; Hashimoto S; Tsuchiya T; Tomida M; Yanagi T
    Technol Cancer Res Treat; 2021; 20():15330338211060170. PubMed ID: 34806489
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment planning strategy for whole-brain radiotherapy with hippocampal sparing and simultaneous integrated boost for multiple brain metastases using intensity-modulated arc therapy.
    Pokhrel D; Sood S; McClinton C; Shen X; Lominska C; Saleh H; Badkul R; Jiang H; Mitchell M; Wang F
    Med Dosim; 2016 Winter; 41(4):315-322. PubMed ID: 27692518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity modulated proton therapy for craniospinal irradiation: organ-at-risk exposure and a low-gradient junctioning technique.
    Stoker JB; Grant J; Zhu XR; Pidikiti R; Mahajan A; Grosshans DR
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):637-44. PubMed ID: 25194667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower doses to hippocampi and other brain structures for skull-base meningiomas with intensity modulated proton therapy compared to photon therapy.
    Florijn MA; Sharfo AWM; Wiggenraad RGJ; van Santvoort JPC; Petoukhova AL; Hoogeman MS; Mast ME; Dirkx MLP
    Radiother Oncol; 2020 Jan; 142():147-153. PubMed ID: 31522879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spot scanning proton arc therapy reduces toxicity in oropharyngeal cancer patients.
    de Jong BA; Battinelli C; Free J; Wagenaar D; Engwall E; Janssens G; Langendijk JA; Korevaar EW; Both S
    Med Phys; 2023 Mar; 50(3):1305-1317. PubMed ID: 36373893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMPT of head and neck cancer: unsupervised machine learning treatment planning strategy for reducing radiation dermatitis.
    Padannayil NM; Sharma DS; Nangia S; Patro KC; Gaikwad U; Burela N
    Radiat Oncol; 2023 Jan; 18(1):11. PubMed ID: 36639667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volumetric modulated arc therapy (VMAT) for hippocampal-avoidance whole brain radiation therapy: planning comparison with Dual-arc and Split-arc partial-field techniques.
    Yuen AHL; Wu PM; Li AKL; Mak PCY
    Radiat Oncol; 2020 Feb; 15(1):42. PubMed ID: 32070385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sparing the hippocampus and the hypothalamic- pituitary region during whole brain radiotherapy: a volumetric modulated arc therapy planning study.
    Mehta P; Janssen S; Fahlbusch FB; Schmid SM; Gebauer J; Cremers F; Ziemann C; Tartz M; Rades D
    BMC Cancer; 2020 Jun; 20(1):610. PubMed ID: 32605648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy.
    Stokkevåg CH; Indelicato DJ; Herfarth K; Magelssen H; Evensen ME; Ugland M; Nordberg T; Nystad TA; Hægeland C; Alsaker MD; Ulven K; Dale JE; Engeseth GM; Boer CG; Toussaint L; Kornerup JS; Pettersen HES; Brydøy M; Brandal P; Muren LP
    Acta Oncol; 2019 Oct; 58(10):1416-1422. PubMed ID: 31364899
    [No Abstract]   [Full Text] [Related]  

  • 12. Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma : A dosimetric comparison.
    Adeberg S; Harrabi SB; Bougatf N; Bernhardt D; Rieber J; Koerber SA; Syed M; Sprave T; Mohr A; Abdollahi A; Haberer T; Combs SE; Herfarth K; Debus J; Rieken S
    Strahlenther Onkol; 2016 Nov; 192(11):770-779. PubMed ID: 27334276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal sparing approach in fractionated stereotactic brain VMAT radio therapy: A retrospective feasibility analysis.
    Daniela Falco M; Giancaterino S; D'Andrea M; Gimenez De Lorenzo R; Trignani M; Caravatta L; Di Carlo C; Di Biase S; Allajbej A; Genovesi D
    J Appl Clin Med Phys; 2018 Jan; 19(1):86-93. PubMed ID: 29125239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction.
    Scorsetti M; Cozzi L; Navarria P; Fogliata A; Rossi A; Franceschini D; De Rose F; Franzese C; Carlo-Stella C; Santoro A
    Radiat Oncol; 2020 Jan; 15(1):12. PubMed ID: 31931861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer.
    Celik E; Baus W; Baues C; Schröder W; Clivio A; Fogliata A; Scorsetti M; Marnitz S; Cozzi L
    Radiat Oncol; 2020 May; 15(1):120. PubMed ID: 32448296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal-sparing whole-brain radiotherapy: a "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy.
    Gondi V; Tolakanahalli R; Mehta MP; Tewatia D; Rowley H; Kuo JS; Khuntia D; Tomé WA
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1244-52. PubMed ID: 20598457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving dosimetric outcome for hippocampus and cochlea sparing whole brain radiotherapy using spot-scanning proton arc therapy.
    Ding X; Zhou J; Li X; Blas K; Liu G; Wang Y; Qin A; Chinnaiyan P; Yan D; Stevens C; Grills I; Kabolizadeh P
    Acta Oncol; 2019 Apr; 58(4):483-490. PubMed ID: 30632851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal tissue complication probability modeling to guide individual treatment planning in pediatric cranial proton and photon radiotherapy.
    Dell'Oro M; Wilson P; Short M; Hua CH; Merchant TE; Bezak E
    Med Phys; 2022 Jan; 49(1):742-755. PubMed ID: 34796509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric impact of bone marrow sparing for robustly optimized IMPT for locally advanced cervical cancer.
    Kuipers SC; Godart J; Corbeau A; Breedveld S; Mens JWM; de Boer SM; Nout RA; Hoogeman MS
    Radiother Oncol; 2024 Jun; 195():110222. PubMed ID: 38471634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating Intensity Modulated Proton Therapy Relative to Passive Scattering Proton Therapy for Increased Vertebral Column Sparing in Craniospinal Irradiation in Growing Pediatric Patients.
    Giantsoudi D; Seco J; Eaton BR; Simeone FJ; Kooy H; Yock TI; Tarbell NJ; DeLaney TF; Adams J; Paganetti H; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):37-46. PubMed ID: 28587051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.